Therapevo Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -14.94%
- Profit Growth -14.28%
- Ebitda -7.84%
- Net Worth 11.30%
- Total Assets 158.59%
About Therapevo Pharmaceuticals
Therapevo Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 December 2018 (Six years and two months 13 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajnish Kumar, Dipa, and Jaya Singh serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239UR2018PTC009273
-
Company No.
009273
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Dec 2018
-
Date of AGM
22 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Therapevo Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajnish Kumar
|
Director | 03-Dec-2018 | Current |
|
Dipa
|
Director | 03-Dec-2018 | Current |
|
Jaya Singh
|
Director | 06-Oct-2021 | Current |
Financial Performance of Therapevo Pharmaceuticals.
Therapevo Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.94% decrease. The company also saw a substantial fall in profitability, with a 14.28% decrease in profit. The company's net worth Soared by an impressive increase of 11.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Therapevo Pharmaceuticals?
Unlock access to Therapevo Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Therapevo Pharmaceuticals?
Unlock and access historical data on people associated with Therapevo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Therapevo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Therapevo Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
